Literature DB >> 26637765

Patient-reported outcomes in clinical practice.

Sarah Dobrozsi1, Julie Panepinto1.   

Abstract

Patient-reported outcome (PRO) measurement plays an increasingly important role in health care and understanding health outcomes. PROs are any report of a patient's health status that comes directly from the patient, and can measure patient symptoms, patient function, and quality-of-life. PROs have been used successfully to assess impairment in a clinical setting. Use of PROs to systematically quantify the patient experience provides valuable data to assist with clinical care; however, initiating use of PROs in clinical practice can be daunting. Here we provide suggestions for implementation of PROs and examples of opportunities to use PROs to tailor individual patient therapy to improve patient outcomes, patient-physician communication, and the quality of care for hematology/oncology patients.
© 2015 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26637765     DOI: 10.1182/asheducation-2015.1.501

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  21 in total

1.  Health-Related Quality of Life and Personal Life Goals of Adults With Sickle Cell Disease After Hematopoietic Stem Cell Transplantation.

Authors:  Agatha M Gallo; Crystal Patil; Tokunbo Adeniyi; Lewis L Hsu; Damiano Rondelli; Santosh Saraf
Journal:  West J Nurs Res       Date:  2018-04-06       Impact factor: 1.967

2.  Associations between interim patient-reported outcome measures and functional status at discharge from rehabilitation for non-specific lumbar impairments.

Authors:  Mark W Werneke; Daniel Deutscher; Julie Fritz; Michael A Kallen; Karon F Cook; Deanna Hayes; Jerome E Mioduski; Linda J Woodhouse
Journal:  Qual Life Res       Date:  2019-09-30       Impact factor: 4.147

Review 3.  Pain-measurement tools in sickle cell disease: where are we now?

Authors:  Deepika S Darbari; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 4.  What is the future of patient-reported outcomes in sickle-cell disease?

Authors:  Sharon A Singh; Nitya Bakshi; Prashant Mahajan; Claudia R Morris
Journal:  Expert Rev Hematol       Date:  2020-10-15       Impact factor: 2.929

5.  Improving the use of patient-reported outcomes among patients receiving radiation therapy during the COVID-19 pandemic.

Authors:  Giovanna Wu; Kimberly McBride; James Loudon
Journal:  J Med Imaging Radiat Sci       Date:  2022-05-25

Review 6.  Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology.

Authors:  Rahma Warsame; Anita D'Souza
Journal:  Mayo Clin Proc       Date:  2019-09-25       Impact factor: 7.616

Review 7.  Value Based Care and Patient-Centered Care: Divergent or Complementary?

Authors:  Eric K Tseng; Lisa K Hicks
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

8.  Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy.

Authors:  Fiona Yeo; Chiu Chin Ng; Kiley W J Loh; Alex Molassiotis; Hui Lin Cheng; Joseph S K Au; Kwun To Leung; Yu Chung Li; Kam-Hung Wong; Lorna Suen; Choi Wan Chan; Janelle Yorke; Carole Farrell; Aishwarya Bandla; Emily Ang; Violeta Lopez; Raghav Sundar; Alexandre Chan
Journal:  Support Care Cancer       Date:  2019-04-10       Impact factor: 3.603

9.  Considerations to Support Use of Patient-Reported Outcomes Measurement Information System Pediatric Measures in Ambulatory Clinics.

Authors:  Elizabeth D Cox; Sarah K Dobrozsi; Christopher B Forrest; Wendy E Gerhardt; Harald Kliems; Bryce B Reeve; Nan E Rothrock; Jin-Shei Lai; Jacob M Svenson; Lindsay A Thompson; Thuy Dan N Tran; Carole A Tucker
Journal:  J Pediatr       Date:  2020-11-30       Impact factor: 4.406

10.  Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study.

Authors:  Kelly Hollis; Christina Proctor; Doreen McBride; Maria-Magdalena Balp; Lori McLeod; Shannon Hunter; Haijun Tian; Sam Khalil; Marcus Maurer
Journal:  Am J Clin Dermatol       Date:  2018-04       Impact factor: 7.403

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.